ARMATA PHARMACEUTICALS, INC. Share Price
ARMATA PHARMACEUTICALS, INC. (ARMP) had Share Price of $6.48 per share as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharePrice · last filed 2026-08-12
- 2026-06-30: Share Price $6.48.
- 2026-03-31: Share Price $10.24.
- 2025-12-31: Share Price $6.28.
- 2025-09-30: Share Price $2.98.
| Period end | Share Price |
|---|---|
| 2026-06-30 | $6.48 10-Q · filed 2026-08-12 |
| 2026-03-31 | $10.24 10-Q · filed 2026-05-13 |
| 2025-12-31 | $6.28 10-K · filed 2026-03-25 |
| 2025-09-30 | $2.98 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.90 10-Q · filed 2025-08-12 |
| 2021-12-31 | $5.48 10-K · filed 2022-03-17 |
| 2018-12-31 | $0.21 10-K · filed 2019-03-25 |
| 2018-06-30 | $1.13 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.09 10-Q · filed 2018-05-15 |
| 2017-12-31 | $1.01 10-K · filed 2018-03-14 |
| 2017-09-19 | $0.99 10-K · filed 2018-03-14 |
| 2017-06-30 | $0.78 10-Q · filed 2017-11-14 |
| 2017-03-31 | $4.30 10-Q · filed 2017-05-15 |
| 2016-12-31 | $4.40 10-K · filed 2018-03-14 |
| 2016-09-30 | $1.52 10-Q · filed 2016-11-10 |
| 2016-06-30 | $1.55 10-Q · filed 2016-08-15 |
| 2016-03-31 | $3.94 10-Q · filed 2016-05-12 |
| 2015-03-31 | $0.30 10-Q · filed 2015-05-15 |
| 2014-12-31 | $0.21 10-Q · filed 2015-05-15 |
| 2014-03-31 | $0.58 10-Q/A · filed 2015-04-15 |
| 2013-12-31 | $0.50 10-Q/A · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |